LncRNA CRNDE and LncRNA SNHG7 Are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Mar 27

PMID 32210611

Citations 12

Authors

Peixian Zhang

Lan Shi

Linjing Song

Yi Long

Kehua Yuan

Wanbao Ding

Lei Deng

Affiliations

Soon will be listed here.

Abstract

Purpose: Synchronous colorectal liver metastasis (SCLM) had limited availability of tools to predict survival and tumor recurrence. LncRNA CRNDE and lncRNA SNHG7 have been proven to be closely related to cancer progression. However, the predictive value of lncRNA CRNDE and lncRNA SNHG7 in cancer prognosis is still unclear. The purpose of this study was to investigate whether lncRNA CRNDE and lncRNA SNHG7 could be used as promising biomarkers for prognosis prediction of SCLM patients who underwent hepatectomy.

Methods: The expression profile of lncRNA CRNDE and lncRNA SNHG7 in serum of SCLM patients was examined by qRT-PCR. The relationship between lncRNA expression and clinicopathological characteristics was analyzed. The Cox proportional-hazards regression model and Kaplan-Meier analysis were performed to analyze the association between lncRNA expression and overall survival (OS) and tumor recurrence of SCLM patients.

Results: Levels of lncRNA CRNDE and lncRNA SNHG7 in patients who underwent recurrence or death were significantly higher than that of patients with recurrence-free or survival (<0.01). Both lncRNA CRNDE high level and lncRNA SNHG7 high level showed a significant correlation with differentiation of primary tumor, invasion depth of primary focus, lymph node metastases, number of liver metastases, and liver metastasis grade. High levels of lncRNA CRNDE or lncRNA SNHG7 predicted shorter recurrence time, shorter OS time, higher recurrence rate and lower OS rate. Furthermore, lncRNA CRNDE and lncRNA SNHG7 were independent risk factors for high recurrence and poor OS in SCLM underwent hepatectomy.

Conclusion: Taken together, lncRNA CRNDE and lncRNA SNHG7 could be promising biomarkers for prediction of OS and tumor recurrence in SCLM underwent hepatectomy.

Citing Articles

lncRNA Biomarkers of Glioblastoma Multiforme.

Pokorna M, Cerna M, Boussios S, Ovsepian S, OLeary V Biomedicines. 2024; 12(5).

PMID: 38790894 PMC: 11117901. DOI: 10.3390/biomedicines12050932.

CRNDE: A Pivotal Oncogenic Long Non-Coding RNA in Cancers.

Hor Y, Salvamani S, Gunasekaran B, Yian K Yale J Biol Med. 2024; 96(4):511-526.

PMID: 38161583 PMC: 10751873. DOI: 10.59249/VHYE2306.

Association between small nucleolar RNA host gene expression and survival outcome of colorectal cancer patients: A meta-analysis based on PRISMA and bioinformatics analysis.

Luo P, Du J, Li Y, Ma J, Shi W Front Oncol. 2023; 13:1094131.

PMID: 36895488 PMC: 9990627. DOI: 10.3389/fonc.2023.1094131.

Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases.

Tang Q, Zeng M, Chen L, Fu N Front Pharmacol. 2022; 13:871100.

PMID: 35721201 PMC: 9201453. DOI: 10.3389/fphar.2022.871100.

Research Progress on the Inflammatory Effects of Long Non-coding RNA in Traumatic Brain Injury.

Wang J, Li C, Ding W, Peng G, Xiao G, Chen R Front Mol Neurosci. 2022; 15:835012.

PMID: 35359568 PMC: 8961287. DOI: 10.3389/fnmol.2022.835012.

References

Janowski E, Timofeeva O, Chasovskikh S, Goldberg M, Kim A, Banovac F . Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies. Oncol Rep. 2016; 37(1):57-65. PMC: 5355723. DOI: 10.3892/or.2016.5284. View

Zhang K, Shi H, Xi H, Wu X, Cui J, Gao Y . Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer. Theranostics. 2017; 7(1):213-227. PMC: 5196898. DOI: 10.7150/thno.16044. View

Xu J, Qin X, Wang J, Zhang S, Zhong Y, Ren L . Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol. 2011; 137(9):1379-96. DOI: 10.1007/s00432-011-0999-8. View

Wang Y, Wang Y, Li J, Zhang Y, Yin H, Han B . CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett. 2015; 367(2):122-8. DOI: 10.1016/j.canlet.2015.03.027. View

Li K, Tang J, Hou Y . LncRNA GATA6-AS inhibits cancer cell migration and invasion in gallbladder cancer by downregulating miR-421. Onco Targets Ther. 2019; 12:8047-8053. PMC: 6778446. DOI: 10.2147/OTT.S212231. View

Xia X, Xue D, Xiang T, Xu H, Song D, Cheng P . Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma. Oncol Lett. 2018; 15(4):4105-4112. PMC: 5844116. DOI: 10.3892/ol.2018.7815. View

Li Z, Tang Y, Xing W, Dong W, Wang Z . LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition. Exp Mol Pathol. 2017; 104(1):19-25. DOI: 10.1016/j.yexmp.2017.12.002. View

Shady W, Petre E, Gonen M, Erinjeri J, Brown K, Covey A . Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. Radiology. 2015; 278(2):601-11. PMC: 4734163. DOI: 10.1148/radiol.2015142489. View

Xu L, Yu X, Wei B, Hui H, Sun Y, Dai J . LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis. Eur Rev Med Pharmacol Sci. 2018; 22(9):2653-2661. DOI: 10.26355/eurrev_201805_14961. View

10.

Zhang W, Yuan W, Song J, Wang S, Gu X . LncRna CPS1-IT1 Suppresses Cell Proliferation, Invasion and Metastasis in Colorectal Cancer. Cell Physiol Biochem. 2017; 44(2):567-580. DOI: 10.1159/000485091. View

11.

Wang F, Cao C, Han K, Zhao Y, Cai M, Xiang Z . APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production. J Clin Invest. 2018; 129(2):727-743. PMC: 6355227. DOI: 10.1172/JCI122478. View

12.

Ding J, Li J, Wang H, Tian Y, Xie M, He X . Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression. Cell Death Dis. 2017; 8(8):e2997. PMC: 5596537. DOI: 10.1038/cddis.2017.328. View

13.

Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J . Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer. 2013; 49(13):2949-59. DOI: 10.1016/j.ejca.2013.04.026. View

14.

Alzahrani N, Ung L, Valle S, Liauw W, Morris D . Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre. ANZ J Surg. 2015; 87(11):E167-E172. DOI: 10.1111/ans.13231. View

15.

Chen Z, Yu C, Zhan L, Pan Y, Chen L, Sun C . LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. Am J Cancer Res. 2016; 6(10):2299-2309. PMC: 5088293. View

16.

Han P, Li J, Zhang B, Lv J, Li Y, Gu X . The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer. 2017; 16(1):9. PMC: 5237133. DOI: 10.1186/s12943-017-0583-1. View

17.

Gong W, Tian M, Qiu H, Yang Z . Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma. Cancer Biomark. 2017; 20(4):417-424. DOI: 10.3233/CBM-170179. View

18.

Reddy S, Parker R, Leach J, Hill M, Burgart L . Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy. J Surg Oncol. 2016; 113(4):456-62. DOI: 10.1002/jso.24144. View

19.

Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B . Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol. 2018; 11(1):89. PMC: 6029165. DOI: 10.1186/s13045-018-0632-2. View

20.

Xiong H, Ni Z, Jiang S, Li X, He J, Gong W . LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene. 2017; 36(25):3528-3540. DOI: 10.1038/onc.2016.521. View